Chilivis Grubman Dalbey & Warner
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • John D. “Randy” Dalbey
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Christian P. Dennis
  • Practice Areas
    • Healthcare
      • Administrative Healthcare
      • Healthcare Audits And Audit Appeals
      • Healthcare Compliance And Audits
      • Healthcare Fraud
      • Healthcare Regulatory Compliance
      • HIPAA
    • White Collar Crime
      • Bank Fraud
      • Grand Jury Investigation
      • Healthcare Fraud
      • Public Corruption
      • Federal Sentencing Issues
      • Internal Investigations
    • Complex Civil Litigation
      • False Claims Act Defense
      • Product Liability
      • Toxic Torts
    • Business Litigation
      • Contracts
    • Professional Misconduct
    • State Bar of Georgia Investigation
    • Data and Cyber Security
    • Government and Public Policy
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
    • Campaign Finance and Election Law
  • Blog
  • News
  • Insights
  • Contact
Select Page

Pain Clinic Owner Sentenced to Over 33 Years in Prison for Role in Pill Mill Operation

Oct 27, 2020 | Government Investigations, Health Care, White Collar Crime

Earlier this year, a jury found Sylvia Hofstetter guilty of a Racketeer Influenced Corrupt Organization (“RICO”) conspiracy, two counts of drug conspiracy, money laundering, and maintaining a drug-involved premise for her role in operating pill mills in Florida and...

Does DOJ’s Antitrust Indictment Signal a New Enforcement Approach Towards the Healthcare Industry?

Oct 20, 2020 | Government Investigations, Health Care, White Collar Crime

The False Claims Act has long been considered one of the Department of Justice’s (“DOJ”) most powerful tools for preventing wrongdoing in the healthcare industry. However, the DOJ’s Antitrust Division has been actively investigating anti-competitive behavior in the...

CMS Revises Policy: Medicare Will Not Cover Multiple COVID-19 Tests Without Order

Aug 31, 2020 | COVID-19 Related Law, Health Care, Medicare and Medicaid

On August 25, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a press release regarding the strengthening of COVID-19 surveillance and the publication of interim final rule CMS-30401-IFC.  Although the press release mainly addresses nursing home...

Multi-Million Dollar Kickback Settlements Continue Despite Covid-19

Aug 31, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid, White Collar Crime

The federal Anti-Kickback Statute (AKS), at its core, prohibits offering, paying, soliciting, or receiving any remuneration in exchange for federal healthcare program referrals.  AKS violations carry potential criminal penalties, as well as civil and administrative...

HHS Permits Pharmacists to Administer Vaccines in All States but Levies Additional Requirements

Aug 21, 2020 | Administrative Law, COVID-19 Related Law, Government Investigations, Health Care

On August 19, 2020, Secretary of the U.S. Department of Health and Human Services (HHS) Alex Azar issued a third amendment to HHS’ Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19 (Directive).  The...

Psychiatrist and Office Manager Indicted for Selling Unapproved Drugs

Aug 13, 2020 | Fraud Investigations, Government Investigations, Health Care, White Collar Crime

On August 7, 2020, the U.S. Department of Justice (“DOJ”) announced the indictment of a psychiatrist and his office manager for allegedly importing and selling drugs not approved by the U.S. Food & Drug Administration (“FDA”).  The DOJ alleges that for ten years,...
« Older Entries
Next Entries »

Recent Posts

  • DOJ Settles FCA Lawsuit Against DME Supplier for $40.5 Million
  • PPP Loan Enforcement Continues: DOJ announces First Civil Settlement for the Cares Act Paycheck Protection Program Fraud
  • Georgia Man That Pled Guilty to Touting Unproven Drugs as COVID-19 Treatment Permanently Barred from Selling Unproven Drugs.
  • EEOC Updates Guidance on Employer Mandated COVID-19 Vaccines
  • Florida Finally Introduces COVID-19 Legislation

Categories

  • Administrative Law
  • Business Litigation
  • Commercial Litigation
  • COVID-19 Related Law
  • Cyber Law
  • DOJ
  • Election Law
  • Employment Law
  • False Claims Act
  • FINRA
  • Firm Announcement
  • Fraud Investigations
  • General
  • Government Investigations
  • Health Care
  • HIPAA
  • Medicare and Medicaid
  • Non-Profit Organizations
  • Uncategorized
  • White Collar Crime
Built by The Montgomery Group